Nova Patents
IL281793B2

Use of cannabinoids in the treatment of epilepsy

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority and filed
  2. Published
  3. Today

Every citation, both ways

Citations
DocumentRelationOfficeCategoryCited duringRelevant claims
WO2008094181A2CitesWorld Intellectual Property Organization (WIPO)YSearch report1-14
WO2012093255A1CitesWorld Intellectual Property Organization (WIPO)YSearch report1-14
ALEXANDRA GEFFREY ET AL,, AMERICAN EPILEPSY SOCIETY | WORKING TOWARD A WORLD WITHOUT EPI, 1 January 2014 (2014-01-01)Non-patent––Search report–
FRED GARDNER,, COMES NOW EPIDIOLEX(TM) (FDA APPROVES IND STUDIES OF CBD), 22 January 2013 (2013-01-22)Non-patent––Search report–
ANONYMOUS,, LEGALIZATION'S OPENING OF MEDICAL POT RESEARCH IS DREAM AND NIGHTMARE - THE DENVER POST, 15 December 2013 (2013-12-15)Non-patent––Search report–
ANONYMOUS,, SALUTARIS DROPS CANNABIDIOL FOR AICARDI SYNDROME - SALUTARIS DROPS, 12 October 2014 (2014-10-12)Non-patent––Search report–
ANONYMOUS,, SALUTARIS DROPS BUY SALUTARIS DROPS - SALUTARIS DROPS, 12 October 2014 (2014-10-12)Non-patent––Search report–
PORTER ET AL.,, REPORT OF A PARENT SURVEY OF CANNABIDIOL-ENRICHED CANNABIS USE IN PEDIATRIC TREATMENT-RESISTANT EPILEPSY, 1 December 2013 (2013-12-01)Non-patent––Search report–
CATHERINE JACOBSON ET AL,, SURVEY OF CURRENT CANNABIDIOL USE IN PEDIATRIC TREATMENT-RESISTANT EPILEPSY, 22 April 2013 (2013-04-22)Non-patent––Search report–
PELLICCIA ET AL.,, TREATMENT WITH CBD IN OILY SOLUTION OF DRUG- RESISTANT PAEDIATRIC EPILEPSIES, 2 October 2010 (2010-10-02)Non-patent––Search report–
ANONYMOUS,, GWPHARMA - GW PHARMACEUTICALS ANNOUNCES EPIDIOLEX RECEIVES FAST TRACK DESIGNATION FROM FDA FOR THE TREATMENT OF DRAVET SYNDROME, 6 June 2014 (2014-06-06)Non-patent––Search report–
MAA ET AL.,, THE CASE FOR MEDICAL MARIJUANA IN EPILEPSY, 1 June 2014 (2014-06-01)Non-patent––Search report–